Dr David Johnson provides his takeaways from this meeting. Part 1 reveals a 'wake-up call' for gastroenterologist burnout and updates in bariatric surgery, Barrett esophagus, G-POEM, NAFLD, and more.

Dr David Johnson reviews the latest data on managing these incidentally detected symptomatic lesions.

A recent study relates future risk to current risk for advanced colorectal cancer. Dr Kerr suggests adding genetic testing to further improve diagnosis.

CDC reviews the latest vaccine recommendations for adults, including patients with chronic medical conditions.

Although not a year for big advances in colorectal cancer, exciting research with current standards was presented at ESMO 2017.

With the 'meteoric' rise of medicinal and recreational cannabinoid use, clinicians should be aware of this idiosyncratic gastrointestinal consequence of cannabinoids.

Dr Alan Jacobs reviews a pilot study's intriguing results.

Dr David Johnson looks at two new reports that may dismiss this association, thereby relieving our patients' worrying.

The guideline also offers tips for enhanced colonoscopy quality, at-risk populations, and age cutoffs. Dr David Johnson shares the highlights.

Physicians from all over the country tell Medscape about their experiences with the ACA. What's your take?